Mission & Vision

ProteomTech's mission is to develop new protein therapeutics for treating illness, improving health, and extending longevity.

ProteomTech, Inc. (PTI) is an emerging product-driven drug development company focusing on developing and producing therapeutic proteins through optimally refolding E. coli inclusion bodies that are difficult to recover by competing technologies. Using its robust, patented protein refolding technology, the Pt-Fold technology, PTI has developed a pipeline of new protein drugs. In addition, PTI is using its China facility for accelerated drug approval and marketing in China, in turn quickly validate the clinical development investment in the US and world market.

PTI has also developed an automated protein refolding system using the core Pt-Fold technology. The automated system is capable of producing a large number of biologically active human proteins at low cost and with high throughput. The automated refolding system enables PTI to serve its customers with high efficiency and low cost.